DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Shree Ram Proteins Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·7 Sept 2026, 4:58 am

Company NSE

Shree Ram Proteins Limited has informed stock exchanges that it has obtained a certificate under SEBI's Depositories and Participants Regulations, 2018. This regulatory compliance confirms that the company's shares are eligible for electronic settlement and trading on the stock market. It is a standard administrative requirement for listed entities to maintain their market eligibility.

For investors, this news is largely procedural and does not signal a change in the company's business performance. The certificate ensures that the company continues to meet the necessary regulatory standards for trading and settlement, maintaining the integrity of the stock market infrastructure.

Investors should monitor the company's future financial disclosures and operational updates rather than focusing on this regulatory filing. This certificate is a routine part of corporate governance and does not impact the stock's intrinsic value or trading status.